BioCareSD is the original specialty distributor, known for outstanding customer service. We feature an ever-expanding portfolio of specialty products in hemotology, immunology, neurology, orphan and other ultra-rare disease states.
January 2023 PRODUCT CATALOG
We have extremely agile and wide-reaching distribution capabilities to support our partners and their patients when they need it most.
We are dedicated to helping our customers save lives —one patient, one product and one promise at a time. BioCareSD, a BioCare Company, is one of the nation’s leading specialty distributors, known for our unparalleled customer service. Our customer support team and local, field-based account management teams are available 24 hours a day, 7 days a week, 365 days a year. We feature an ever-expanding portfolio of specialty products for hematology, thrombophilia, immunology, neurology, ophthalmology, orphan and other ultra-rare diseases. BioCareSD is an Authorized Distributor of Record for all the manufacturers we represent, so you can depend on the quality of our products. We believe that trusted partnerships are pivotal to supporting patients needs. We are proud to support our partners in their mission to save lives.
Spokane
Seattle
Milwaukee
Providence
Ramsey
Montvale
Pittsburgh
Westbury
Dayton
Denver
Kansas City
Las Vegas
Olive Branch
Tempe
El Paso
Dallas
Lafayette
We will do whatever it takes to provide our partners with unmatched service-levels.
There is always a live BioCareSD® Team member to answer your calls 24/7/365
We are always at your service.
Our distribution network is within a 6 hour delivery window
Celebrating Over
Outstanding customer service is who we are. We are people who care
in Specialty Distribution
3
BioCareSD In the News...
January 2023
The BioCare team celebrates and recognizes the following holidays and events this month.
The Intricacies of the Pharma Cold Chain
Tom Hart, Chief Operating Officer of BioCare, discusses how extreme temperatures affect cold chains and what supply chain players can do to minimize impacts and delays caused by weather.
January 1 NEW YEAR’S DAY
We partner with our customers to deliver the best possible care to patients all over the country. We spare no effort to ensure every customer has, on hand, the inventory they need, when they need it and that there is always a live voice at the other end of the line when duty calls. It is our promise to deliver unparalleled service to our partners and their patients. At the end of every journey there is a patient waiting for life-saving therapeutics.
January 16 MARTIN LUTHER KING DAY
Read More
Creating A Sense Of Togetherness For Your Team In A Remote Work Environment
Andrew Kirk, Chief Revenue Officer of BioCare, details tips and strategies that leaders can implement to bring their teams together and build connection despite being physically apart.
Read More
We are people who care.
Visit our News & Insights page for the latest BioCare case studies, news stories, and industry insights.
View News & Insights
Follow us
5
Always at your service.
Product Catalog
ASCENIV™ is the only IVIG produced from blending RSV plasma and normal source plasma 1
Learn More About ASCENIV and the ADvantage Ig Patient Support Program at ASCENIV.com
Indication ASCENIV (immune globulin intravenous, human – slra) is a 10% immune globulin liquid for intravenous injection, indicated for the treatment of primary humoral immunodeficiency (PI) in adults and adolescents (12 to 17 years of age). PI includes, but is not limited to, the humoral immune defect in congenital agammaglobulinemia, common variable immunodeficiency (CVID), X linked agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies (SCID). Contraindications ASCENIV is contraindicated in: • Patients who have had an anaphylactic or severe systemic reaction to the administration of human immune globulin. • IgA-deficiency patients with antibodies to IgA and a history of hypersensitivity. Warnings and Precautions Severe hypersensitivity reactions may occur with IGIV products, including ASCENIV. In case of hypersensitivity, discontinue ASCENIV infusion immediately and institute appropriate treatment. Patients with known antibodies to IgA may have a greater risk of developing potentially severe hypersensitivity and anaphylactic reactions. Thrombosis may occur following treatment with immunoglobulin products and in the absence of known risk factors. Consider baseline assessment of blood viscosity in patients at risk for hyperviscosity and ensure adequate hydration before administration. For patients at risk of thrombosis, administer ASCENIV at the minimum dose and infusion rate practicable. Monitor for signs and symptoms of thrombosis and assess blood viscosity in patients at risk for hyperviscosity. Acute renal dysfunction/failure, osmotic nephrosis, and death may occur upon use of human IGIV products. Ensure that patients are not volume depleted before administering ASCENIV. Periodic monitoring of renal function and urine output is particularly important in patients judged to be at increased risk of developing acute renal failure. Assess renal function, including measurement of blood urea nitrogen (BUN) and serum creatinine, before the initial infusion of ASCENIV and at appropriate intervals thereafter. Discontinue ASCENIV if renal function deteriorates. In at risk patients, administer ASCENIV at the minimum infusion rate practicable. Hyperproteinemia, increased serum viscosity, and hyponatremia or pseudohyponatremia may occur in patients receiving IGIV treatment, including ASCENIV. It is critical to clinically distinguish true hyponatremia from a pseudohyponatremia that is associated with or causally related to hyperproteinemia. Treatment aimed at decreasing serum free water in patients with pseudohyponatremia may lead to volume depletion, a further increase in serum viscosity, and a possible predisposition to thrombotic events. Aseptic meningitis syndrome (AMS) may occur with IGIV treatments, including ASCENIV. AMS usually begins within several hours to 2 days following IGIV treatment. AMS may occur more frequently in association with high doses (2 g/kg) and/or rapid infusion of IGIV. Conduct a thorough neurological examination on patients exhibiting signs and symptoms of AMS, including cerebrospinal fluid (CSF) studies, to rule out other causes of meningitis. IGIV products, including ASCENIV, may contain blood group antibodies that can act as hemolysins and induce in vivo coating of red blood cells (RBCs) with immunoglobulin, causing a positive direct antiglobulin reaction and hemolysis. Monitor patients for clinical signs and symptoms of hemolysis, including appropriate confirmatory laboratory testing. Non-cardiogenic pulmonary edema may occur with IV administered IG. Monitor patients for pulmonary adverse reactions. If suspected, perform appropriate tests for presence of anti-neutrophil in both product and patient serum. May be managed using oxygen therapy with adequate ventilatory support. Because ASCENIV is made from human blood, it may carry a risk of transmitting infectious agents, e.g., viruses, the variant Creutzfeldt-Jakob disease (vCJD) and theoretically, the Creutzfeldt-Jakob disease (CJD) agent. All infections suspected by a physician to possibly have been transmitted by this product should be reported to ADMA Biologics at (1-800-458-4244) . After infusion of immunoglobulin, the transitory rise of the various passively transferred antibodies in the patient’s blood may yield positive serological testing results, with the potential for misleading interpretation. Passive transmission of antibodies to erythrocyte antigens (e.g., A, B, and D) may cause a positive direct or indirect antiglobulin (Coombs’) test. Adverse Reactions The most common adverse reactions to ASCENIV ( ≥ 5% of study subjects) were headache, sinusitis, diarrhea, gastroenteritis viral, nasopharyngitis, upper respiratory tract infection, bronchitis, and nausea.
1. Data on File, ADMA Biologics. IT’S WHAT’S INSIDE THAT COUNTS For patients with primary humoral immunodeficiency (PI)
www.asceniv.com
Focused on what matters most: safety, quality, and efficacy
Important Safety Information for ASCENIV™ WARNING: THROMBOSIS, RENAL DYSFUNCTION AND ACUTE RENAL FAILURE
Thrombosis may occur with immune globulin intravenous (IGIV) products, including ASCENIV. Risk factors may include: advanced age, prolonged immobilization, hypercoagulable conditions, history of venous or arterial thrombosis, use of estrogens, indwelling central vascular catheters, hyperviscosity, and cardiovascular risk factors. Thrombosis may occur in the absence of known risk factors. Renal dysfunction, acute renal failure, osmotic nephrosis, and death may occur with the administration of Immune Globulin Intravenous (Human) (IGIV) products in predisposed patients. Renal dysfunction and acute renal failure occur more commonly in patients receiving IGIV products containing sucrose. ASCENIV does not contain sucrose. For patients at risk of thrombosis, renal dysfunction or renal failure, administer ASCENIV at the minimum dose and infusion rate practicable. Ensure adequate hydration in patients before administration. Monitor for signs and symptoms of thrombosis and assess blood viscosity in patients at risk for hyperviscosity.
You are encouraged to report side effects of prescription drugs to ADMA Biologics @ 1-800-458-4244 or the FDA. Visit www.fda.gov/MedWatch or call 1-800-FDA-1088. For additional safety information about ASCENIV, please see full Prescribing Information.
© 2023 ADMA Biologics. All rights reserved. ASCENIV™ is a trademark of ADMA Biologics. Visit admabiologics.com
AP ALBUMIN PRODUCTS Product Name Package Size NDC #
HP HEMATOLOGY PRODUCTS Product Name Package Size NDC #
Product Category
Product Category
Presentation
Subcategory Derivation
Manufacturer
Presentation
Subcategory
Derivation
Manufacturer
ALBUMIN/PLASMA PROTEIN FRACTION
ANTI-INHIBITOR COAGULANT COMPLEX
ANTI-INHIBITOR COAGULANT COMPL ANTI-INHIBITOR COAGULANT COMPL ANTI-INHIBITOR COAGULANT COMPL ANTI-INHIBITOR COAGULANT COMPL ANTI-INHIBITOR COAGULANT COMPL ANTI-INHIBITOR COAGULANT COMPL ANTI-INHIBITOR COAGULANT COMPL
ALBURX
25% 50mL 44206-0251-05
VIAL
ALBUMIN
PLASMA
CSL BEHRING LLC
TAKEDA PHARMACEUTICALS AMERICAS, INC.
FEIBA
1000 IU 64193-0424-02
VIAL
INHIBITORS
PLASMA
ALBURX
25% 100mL 44206-0251-10
VIAL
ALBUMIN
PLASMA
CSL BEHRING LLC
TAKEDA PHARMACEUTICALS AMERICAS, INC.
FEIBA
2000 IU 64193-0425-02
VIAL
INHIBITORS
PLASMA
ALBURX
5% 250mL 44206-0310-25
VIAL
ALBUMIN
PLASMA
CSL BEHRING LLC
ALBURX
5% 500mL 44206-0310-50
VIAL
ALBUMIN
PLASMA
CSL BEHRING LLC
TAKEDA PHARMACEUTICALS AMERICAS, INC.
FEIBA
500 IU 64193-0426-02
VIAL
INHIBITORS
PLASMA
ALBUTEIN
5% 250mL
68516-5214-01
VIAL
ALBUMIN
PLASMA
GRIFOLS USA, LLC
MONOCLONAL ANTIBODY
ALBUTEIN
5% 500mL
68516-5214-02
VIAL
ALBUMIN
PLASMA
GRIFOLS USA, LLC
HEMLIBRA
30 MG 50242-0920-01
VIAL
NONFACTOR
GENENTECH USA, INC.
ALBUTEIN
5% 50mL
68516-5214-05
VIAL
ALBUMIN
PLASMA
GRIFOLS USA, LLC
MONOCLONAL ANTIBODY
HEMLIBRA
60 MG 50242-0921-01
VIAL
NONFACTOR
GENENTECH USA, INC.
ALBUTEIN
25% 50mL
68516-5216-01
VIAL
ALBUMIN
PLASMA
GRIFOLS USA, LLC
ALBUTEIN
25% 100mL 68516-5216-02
VIAL
ALBUMIN
PLASMA
GRIFOLS USA, LLC
MONOCLONAL ANTIBODY
HEMLIBRA
105 MG 50242-0922-01
VIAL
NONFACTOR
GENENTECH USA, INC.
ALBUTEIN
25% 20mL
68516-5216-05
VIAL
ALBUMIN
PLASMA
GRIFOLS USA, LLC
MONOCLONAL ANTIBODY
25% 25 GM / 100 ML
HEMLIBRA
150 MG 50242-0923-01
VIAL
NONFACTOR
GENENTECH USA, INC.
ALBUTEIN FLEXBAG
68516-5216-00
5 PACK
ALBUMIN
PLASMA
GRIFOLS USA, LLC
ALBUTEIN FLEXBAG
5% 500mL 68516-5214-00
2 PACK
ALBUMIN
PLASMA
GRIFOLS USA, LLC
ANTITHROMBIN
ALBUTEIN FLEXBAG
5% 250mL
68516-5214-09
4 PACK
ALBUMIN
PLASMA
GRIFOLS USA, LLC
THROMBATE III
500 IU
13533-0606-12
VIAL
COAGULANT ANTITHROMBIN PLASMA
GRIFOLS USA, LLC
25% 12.5 GM / 50 ML
ALBUTEIN FLEXBAG
68516-5216-09
5 PACK
ALBUMIN
PLASMA
GRIFOLS USA, LLC
FACTOR I
ALBUKED
5% 250mL
76125-0790-25
VIAL
ALBUMIN
PLASMA
KEDRION BIOPHARMA
FIBRYGA
1 GRAM 68982-0347-01
VIAL
COAGULANT
FACTOR I
PLASMA
OCTAPHARMA USA
ALBUKED
5% 50mL
76125-0790-05
VIAL
ALBUMIN
PLASMA
KEDRION BIOPHARMA
RIASTAP
1000 IU 63833-0891-51
VIAL
COAGULANT
FACTOR I
PLASMA
CSL BEHRING LLC
ALBUKED
25% 100 mL 76125-0792-10
VIAL
ALBUMIN
PLASMA
KEDRION BIOPHARMA
FACTOR IX
ALBUKED
25% 20mL
76125-0792-20
VIAL
ALBUMIN
PLASMA
KEDRION BIOPHARMA
ALPHANINE
500 IU
68516-3610-02
VIAL
COAGULANT FACTOR IX
PLASMA
GRIFOLS USA, LLC
ALBUKED
25% 50 mL 76125-0792-25
VIAL
ALBUMIN
PLASMA
KEDRION BIOPHARMA
ALBUMIN
5% 250mL 68982-0623-02
VIAL
ALBUMIN
PLASMA
OCTAPHARMA USA
ALPHANINE
1000 IU
68516-3611-02
VIAL
COAGULANT FACTOR IX
PLASMA
GRIFOLS USA, LLC
ALBUMIN
5% 500mL 68982-0623-03
VIAL
ALBUMIN
PLASMA
OCTAPHARMA USA
ALPHANINE
1500 IU 68516-3612-02
VIAL
COAGULANT FACTOR IX
PLASMA
GRIFOLS USA, LLC
ALBUMIN
5% 100mL 68982-0623-01
VIAL
ALBUMIN
PLASMA
OCTAPHARMA USA
ALPROLIX
500 IU
71104-0911-01
VIAL
COAGULANT FACTOR IX RECOMBINANT
SANOFI GENZYME
ALBUMIN
20% 50mL 68982-0633-01
VIAL
ALBUMIN
PLASMA
OCTAPHARMA USA
ALPROLIX
1000 IU 71104-0922-01
VIAL
COAGULANT FACTOR IX RECOMBINANT
SANOFI GENZYME
ALBUMIN
20% 100mL 68982-0633-02
VIAL
ALBUMIN
PLASMA
OCTAPHARMA USA
ALPROLIX
2000 IU 71104-0933-01
VIAL
COAGULANT FACTOR IX RECOMBINANT
SANOFI GENZYME
ALBUMIN
25% 50mL
68982-0643-01
VIAL
ALBUMIN
PLASMA
OCTAPHARMA USA
ALBUMIN
25% 100mL 68982-0643-02
VIAL
ALBUMIN
PLASMA
OCTAPHARMA USA
ALPROLIX
3000 IU 71104-0944-01
VIAL
COAGULANT FACTOR IX RECOMBINANT
SANOFI GENZYME
TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC.
FLEXBUMIN
25% 50mL 00944-0493-01
BAG
ALBUMIN
PLASMA
ALPROLIX
250 IU
71104-0966-01
VIAL
COAGULANT FACTOR IX RECOMBINANT
SANOFI GENZYME
FLEXBUMIN
25% 100mL 00944-0493-02
BAG
ALBUMIN
PLASMA
ALPROLIX
4000 IU 71104-0977-01
VIAL
COAGULANT FACTOR IX RECOMBINANT
SANOFI GENZYME
FLEXBUMIN
5% 250mL 00944-0495-05
BAG
ALBUMIN
PLASMA
11
HP HEMATOLOGY PRODUCTS Product Name Package Size NDC #
HP HEMATOLOGY PRODUCTS Product Name Package Size NDC #
Product Category
Product Category
Presentation
Subcategory
Derivation
Manufacturer
Presentation
Subcategory
Derivation
Manufacturer
FACTOR IX COM- PLEX FACTOR IX COM- PLEX FACTOR IX COM- PLEX
BENEFIX RT
250 IU 58394-0633-03
VIAL
COAGULANT FACTOR IX RECOMBINANT
PFIZER, INC.
PROFILNINE
500 IU
68516-3210-01
VIAL
COAGULANT
PLASMA
GRIFOLS USA, LLC
BENEFIX RT
500 IU 58394-0634-03
VIAL
COAGULANT FACTOR IX RECOMBINANT
PFIZER, INC.
PROFILNINE
1000 IU
68516-3211-02
VIAL
COAGULANT
PLASMA
GRIFOLS USA, LLC
BENEFIX RT
1000 IU 58394-0635-03
VIAL
COAGULANT FACTOR IX RECOMBINANT
PFIZER, INC.
PROFILNINE
1500 IU 68516-3212-02
VIAL
COAGULANT
PLASMA
GRIFOLS USA, LLC
FACTOR VIIA
BENEFIX RT
2000 IU 58394-0636-03
VIAL
COAGULANT FACTOR IX RECOMBINANT
PFIZER, INC.
BENEFIX RT
3000 IU 58394-0637-03
VIAL
COAGULANT FACTOR IX RECOMBINANT
PFIZER, INC.
NOVOSEVEN RT
1 MG
00169-7201-01
VIAL
INHIBITORS FACTOR VIIA RECOMBINANT NOVO NORDISK INC.
IDELVION
250 IU
69911-0864-02
VIAL
COAGULANT FACTOR IX RECOMBINANT
CSL BEHRING LLC
NOVOSEVEN RT
2 MG
00169-7202-01
VIAL
INHIBITORS FACTOR VIIA RECOMBINANT NOVO NORDISK INC.
IDELVION
500 IU
69911-0865-02
VIAL
COAGULANT FACTOR IX RECOMBINANT
CSL BEHRING LLC
NOVOSEVEN RT
5 MG
00169-7205-01
VIAL
INHIBITORS FACTOR VIIA RECOMBINANT NOVO NORDISK INC.
IDELVION
1000 IU 69911-0866-02
VIAL
COAGULANT FACTOR IX RECOMBINANT
CSL BEHRING LLC
NOVOSEVEN RT
8 MG
00169-7208-01
VIAL
INHIBITORS FACTOR VIIA RECOMBINANT NOVO NORDISK INC.
IDELVION
2000 IU 69911-0867-02
VIAL
COAGULANT FACTOR IX RECOMBINANT
CSL BEHRING LLC
SEVENFACT
1MG
71127-1000-01
VIAL
INHIBITORS FACTOR VIIA RECOMBINANT
HEMA BIOLOGICS
IDELVION
3500 IU 69911-0869-02
VIAL
COAGULANT FACTOR IX RECOMBINANT
CSL BEHRING LLC
SEVENFACT
5MG
71127-5000-01
VIAL
INHIBITORS FACTOR VIIA RECOMBINANT
HEMA BIOLOGICS
FACTOR VIII
REBINYN
1000 IU 00169-7901-01
VIAL
COAGULANT FACTOR IX RECOMBINANT NOVO NORDISK INC.
1801 IU - 2400 IU 2401 IU - 3600 IU 3601 IU - 4800 IU
TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC.
REBINYN
2000 IU 00169-7902-01
VIAL
COAGULANT FACTOR IX RECOMBINANT NOVO NORDISK INC.
ADVATE
00944-3045-10
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
REBINYN
500 IU
00169-7905-01
VIAL
COAGULANT FACTOR IX RECOMBINANT NOVO NORDISK INC.
ADVATE
00944-3046-10
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC.
RIXUBIS
250 IU 00944-3026-02
VIAL
COAGULANT FACTOR IX RECOMBINANT
ADVATE
00944-3047-10
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
RIXUBIS
500 IU 00944-3028-02
VIAL
COAGULANT FACTOR IX RECOMBINANT
ADVATE
200 IU - 400 IU 00944-3051-02
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
RIXUBIS
1000 IU 00944-3030-02
VIAL
COAGULANT FACTOR IX RECOMBINANT
ADVATE
401 IU - 800 IU 00944-3052-02
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
801 IU - 1200 IU 1201 IU - 1800 IU
RIXUBIS
2000 IU 00944-3032-02
VIAL
COAGULANT FACTOR IX RECOMBINANT
ADVATE
00944-3053-02
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
RIXUBIS
3000 IU 00944-3034-02
VIAL
COAGULANT FACTOR IX RECOMBINANT
ADVATE
00944-3054-02
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
FACTOR IX COMPLEX
ADYNOVATE
401 IU - 800 IU 00944-4623-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
FACTOR IX COM- PLEX FACTOR IX COM- PLEX FACTOR IX COM- PLEX FACTOR IX COM- PLEX FACTOR IX COM- PLEX
KCENTRA
500 IU 63833-0386-02
VIAL
COAGULANT
PLASMA
CSL BEHRING LLC
ADYNOVATE
801 IU - 1250 IU 00944-4624-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
KCENTRA
1000 IU 63833-0387-02
VIAL
COAGULANT
PLASMA
CSL BEHRING LLC
ADYNOVATE
1801-2500 IU 00944-4625-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
PROFILNINE
500 IU
68516-3207-01
VIAL
COAGULANT
PLASMA
GRIFOLS USA, LLC
ADYNOVATE
750 IU 00944-4626-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
PROFILNINE
1000 IU 68516-3208-02
VIAL
COAGULANT
PLASMA
GRIFOLS USA, LLC
ADYNOVATE
1500 IU 00944-4627-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
PROFILNINE
1500 IU 68516-3209-02
VIAL
COAGULANT
PLASMA
GRIFOLS USA, LLC
ADYNOVATE
3000 IU 00944-4628-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
13
HP HEMATOLOGY PRODUCTS Product Name Package Size NDC #
HP HEMATOLOGY PRODUCTS Product Name Package Size NDC #
Product Category
Product Category
Presentation
Subcategory
Derivation
Manufacturer
Presentation
Subcategory
Derivation
Manufacturer
801 IU – 1200 IU 1201 IU – 2000 IU
TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC.
AFSTYLA
250 IU
69911-0474-02
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
CSL BEHRING LLC
HEMOFIL
00944-3944-02
VIAL
COAGULANT FACTOR VIII
PLASMA
AFSTYLA
500 IU
69911-0475-02
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
CSL BEHRING LLC
HEMOFIL
00944-3946-02
VIAL
COAGULANT FACTOR VIII
PLASMA
AFSTYLA
1000 IU 69911-0476-02
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
CSL BEHRING LLC
JIVI
500 IU 00026-3942-25
VIAL
COAGULANT FACTOR VIII
RECOMBINANT BAYER CORPORATION
AFSTYLA
2000 IU 69911-0477-02
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
CSL BEHRING LLC
JIVI
1000 IU 00026-3944-25
VIAL
COAGULANT FACTOR VIII
RECOMBINANT BAYER CORPORATION
AFSTYLA
3000 IU 69911-0478-02
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
CSL BEHRING LLC
JIVI
2000 IU 00026-3946-25
VIAL
COAGULANT FACTOR VIII
RECOMBINANT BAYER CORPORATION
AFSTYLA
1500 IU 69911-0480-02
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
CSL BEHRING LLC
JIVI
3000 IU 00026-3948-25
VIAL
COAGULANT FACTOR VIII
RECOMBINANT BAYER CORPORATION
AFSTYLA
2500 IU 69911-0481-02
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
CSL BEHRING LLC
KOATE
250 IU
76125-0257-25
VIAL
COAGULANT FACTOR VIII
PLASMA
KEDRION BIOPHARMA
ELOCTATE
250 IU
71104-0801-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
SANOFI GENZYME
KOATE
500 IU
76125-0663-50
VIAL
COAGULANT FACTOR VIII
PLASMA
KEDRION BIOPHARMA
ELOCTATE
500 IU
71104-0802-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
SANOFI GENZYME
KOATE
1000 IU 76125-0676-50
VIAL
COAGULANT FACTOR VIII
PLASMA
KEDRION BIOPHARMA
ELOCTATE
700 IU
71104-0803-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
SANOFI GENZYME
KOGENATE
250 IU 00026-3782-25
VIAL
COAGULANT FACTOR VIII
RECOMBINANT BAYER CORPORATION
ELOCTATE
1000 IU 71104-0804-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
SANOFI GENZYME
KOGENATE
500 IU 00026-3783-35
VIAL
COAGULANT FACTOR VIII
RECOMBINANT BAYER CORPORATION
ELOCTATE
1500 IU 71104-0805-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
SANOFI GENZYME
KOGENATE
1000 IU 00026-3785-55
VIAL
COAGULANT FACTOR VIII
RECOMBINANT BAYER CORPORATION
ELOCTATE
2000 IU 71104-0806-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
SANOFI GENZYME
KOGENATE
2000 IU 00026-3786-65
VIAL
COAGULANT FACTOR VIII
RECOMBINANT BAYER CORPORATION
ELOCTATE
3000 IU 71104-0807-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
SANOFI GENZYME
KOGENATE
3000 IU 00026-3787-75
VIAL
COAGULANT FACTOR VIII
RECOMBINANT BAYER CORPORATION
ELOCTATE
4000 IU 71104-0808-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
SANOFI GENZYME
KOVALTRY
250 IU
00026-3821-25
VIAL
COAGULANT FACTOR VIII
RECOMBINANT BAYER CORPORATION
KOVALTRY
500 IU 00026-3822-25
VIAL
COAGULANT FACTOR VIII
RECOMBINANT BAYER CORPORATION
ELOCTATE
5000 IU 71104-0809-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
SANOFI GENZYME
KOVALTRY
1000 IU 00026-3824-25
VIAL
COAGULANT FACTOR VIII
RECOMBINANT BAYER CORPORATION
ELOCTATE
6000 IU 71104-0810-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
SANOFI GENZYME
KOVALTRY
2000 IU 00026-3826-50
VIAL
COAGULANT FACTOR VIII
RECOMBINANT BAYER CORPORATION
ESPEROCT
1000 IU 00169-8100-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT NOVO NORDISK INC.
KOVALTRY
3000 IU 00026-3828-50
VIAL
COAGULANT FACTOR VIII
RECOMBINANT BAYER CORPORATION
ESPEROCT
1500 IU 00169-8150-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT NOVO NORDISK INC.
NOVOEIGHT
1000 IU 00169-7810-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT NOVO NORDISK INC.
ESPEROCT
2000 IU 00169-8200-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT NOVO NORDISK INC.
NOVOEIGHT
1500 IU
00169-7815-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT NOVO NORDISK INC.
NOVOEIGHT
2000 IU 00169-7820-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT NOVO NORDISK INC.
ESPEROCT
3000 IU 00169-8300-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT NOVO NORDISK INC.
NOVOEIGHT
250 IU
00169-7825-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT NOVO NORDISK INC.
ESPEROCT
500 IU 00169-8500-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT NOVO NORDISK INC.
NOVOEIGHT
3000 IU 00169-7830-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT NOVO NORDISK INC.
TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC.
HEMOFIL
220 IU – 400 IU 00944-3940-02
VIAL
COAGULANT FACTOR VIII
PLASMA
NOVOEIGHT
500 IU
00169-7850-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT NOVO NORDISK INC.
HEMOFIL
401 IU – 800 IU 00944-3942-02
VIAL
COAGULANT FACTOR VIII
PLASMA
NUWIQ
250 IU
68982-0139-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
OCTAPHARMA USA
15
HP HEMATOLOGY PRODUCTS Product Name Package Size NDC #
HP HEMATOLOGY PRODUCTS Product Name Package Size NDC #
Product Category
Product Category
Presentation
Subcategory
Derivation
Manufacturer
Presentation
Subcategory
Derivation
Manufacturer
XYNTHA SOLOFUSE
2000 IU 58394-0025-03
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
PFIZER, INC.
NUWIQ
500 IU
68982-0141-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
OCTAPHARMA USA
XYNTHA SOLOFUSE
250 IU 58394-0022-03
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
PFIZER, INC.
NUWIQ
1000 IU 68982-0143-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
OCTAPHARMA USA
XYNTHA SOLOFUSE
500 IU 58394-0023-03
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
PFIZER, INC.
NUWIQ
1500 IU 68982-0153-01
Vial
COAGULANT FACTOR VIII
RECOMBINANT
OCTAPHARMA USA
FACTOR VIII WITH VON WILLEBRAND FACTOR
FACTOR VIII WITH VWF FACTOR VIII WITH VWF FACTOR VIII WITH VWF FACTOR VIII WITH VWF FACTOR VIII WITH VWF FACTOR VIII WITH VWF FACTOR VIII WITH VWF FACTOR VIII WITH VWF FACTOR VIII WITH VWF FACTOR VIII WITH VWF FACTOR VIII WITH VWF
NUWIQ
2000 IU 68982-0145-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
OCTAPHARMA USA
ALPHANATE
250 IU
68516-4611-01
VIAL
COAGULANT
PLASMA
GRIFOLS USA, LLC
ALPHANATE
250 IU
68516-4616-01
VIAL
COAGULANT
PLASMA
GRIFOLS USA, LLC
NUWIQ
2500 IU 68982-0147-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
OCTAPHARMA USA
ALPHANATE
500 IU
68516-4617-01
VIAL
COAGULANT
PLASMA
GRIFOLS USA, LLC
NUWIQ
3000 IU 68982-0149-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
OCTAPHARMA USA
ALPHANATE
1000 IU 68516-4618-02
VIAL
COAGULANT
PLASMA
GRIFOLS USA, LLC
NUWIQ
4000 IU 68982-0151-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
OCTAPHARMA USA
ALPHANATE
1500 IU 68516-4619-02
VIAL
COAGULANT
PLASMA
GRIFOLS USA, LLC
TAKEDA PHARMACEUTICALS AMERICAS, INC.
OBIZUR
1-PACK 500 AU 00944-5001-01
VIAL
INHIBITORS
FACTOR VIII
RECOMBINANT
ALPHANATE
2000 IU 68516-4620-02
VIAL
COAGULANT
PLASMA
GRIFOLS USA, LLC
OBIZUR-RECOMBI- NANT FACTOR VIII SUBSTRATE
1 CARTON = 1 VIAL
TAKEDA PHARMACEUTICALS AMERICAS, INC.
1505746
VIAL
INHIBITORS
FACTOR VIII
RECOMBINANT
HUMATE-P
600 RCOF
63833-0615-02
VIAL
COAGULANT
PLASMA
CSL BEHRING LLC
HUMATE-P
1200 RCOF
63833-0616-02
VIAL
COAGULANT
PLASMA
CSL BEHRING LLC
2000 IU - 3125 IU
TRETTEN
00169-7013-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT NOVO NORDISK INC.
HUMATE-P
2400 RCOF
63833-0617-02
VIAL
COAGULANT
PLASMA
CSL BEHRING LLC
TAKEDA PHARMACEUTICALS AMERICAS, INC.
RECOMBINATE
220 IU – 400 IU 00944-2841-10
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
WILATE
500 RCOF
68982-0182-01
VIAL
COAGULANT
PLASMA
OCTAPHARMA USA
TAKEDA PHARMACEUTICALS AMERICAS, INC.
RECOMBINATE
401 IU – 800 IU 00944-2842-10
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
WILATE
1000 RCOF
68982-0182-02
VIAL
COAGULANT
PLASMA
OCTAPHARMA USA
801 IU – 1240 IU
TAKEDA PHARMACEUTICALS AMERICAS, INC.
RECOMBINATE
00944-2843-10
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
FACTOR X
BIO PRODUCTS LABORATORIES BIO PRODUCTS LABORATORIES
TAKEDA PHARMACEUTICALS AMERICAS, INC.
COAGADEX
250 IU
64208-7752-01
VIAL
COAGULANT FACTOR X
PLASMA
RECOMBINATE
1241-1800 IU 00944-2844-10
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
COAGADEX
500 IU
64208-7753-01
VIAL
COAGULANT FACTOR X
PLASMA
TAKEDA PHARMACEUTICALS AMERICAS, INC.
RECOMBINATE
1801 – 2400 IU 00944-2845-10
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
FACTOR XA
XYNTHA
250 IU
58394-0012-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
PFIZER, INC.
CARTON: 4 VIALS/CTN
ANDEXXA
200 MG VIAL 69853-0102-01
COAGULANT FACTOR XA RECOMBINANT
ALEXION
XYNTHA
500 IU
58394-0013-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
PFIZER, INC.
FACTOR XIII
XYNTHA
1000 IU 58394-0014-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
PFIZER, INC.
CORIFACT
1000 IU 63833-0518-02
VIAL
COAGULANT FACTOR XIII
PLASMA
CSL BEHRING LLC
VON WILLEBRAND FACTOR
XYNTHA
2000 IU 58394-0015-01
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
PFIZER, INC.
VON WILLE- BRAND FACTOR VON WILLE- BRAND FACTOR
CABLIVI
11 MG
58468-0225-01
VIAL
COAGULANT
RECOMBINANT
SANOFI GENZYME
XYNTHA SOLOFUSE
3000 IU 58394-0016-03
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
PFIZER, INC.
TAKEDA PHARMACEUTICALS AMERICAS, INC.
VONVENDI
450 – 850 IU 00944-7551-02
VIAL
COAGULANT
RECOMBINANT
XYNTHA SOLOFUSE
1000 IU 58394-0024-03
VIAL
COAGULANT FACTOR VIII
RECOMBINANT
PFIZER, INC.
17
HG IMMUNOLOGY PRODUCTS - HYPERIMMUNE GLOBULIN Product Name Package Size NDC # Presentation Product Category Subcategory Derivation
Manufacturer
CYTOMEGALOVIRUS IMMUNE GLOBULIN
CYTOGAM
2.5 GRAMS 70257-0532-51
VIAL
HYPER IMMUNE
IG
PLASMA SAOL THERAPEUTICS, INC.
INTRAMUSCULAR IMMUNE GLOBULIN
GAMASTAN
2 ML
13533-0335-04
VIAL
HYPER IMMUNE
IG
PLASMA
GRIFOLS USA, LLC
GAMASTAN
10 ML
13533-0335-12
VIAL
HYPER IMMUNE
IG
PLASMA
GRIFOLS USA, LLC
HEPATITIS B IMMUNE GLOBULIN
HEPAGAM
5 ML
70257-0051-51
VIAL
HYPER IMMUNE
IG
PLASMA SAOL THERAPEUTICS, INC.
Simplify access to ASCENIV ™ & BIVIGAM ® for your patients When you decide that IVIG treatment is right for your patient, enroll them in the support program that can help connect them with potential financial assistance.
HEPAGAM
1 ML
70257-0052-51
VIAL
HYPER IMMUNE
IG
PLASMA SAOL THERAPEUTICS, INC.
HYPERHEP B
0.5ML VIAL 13533-0636-03
VIAL
HYPER IMMUNE
IG
PLASMA
GRIFOLS USA, LLC
HYPERHEP B
1 ML VIAL
13533-0636-02
VIAL
HYPER IMMUNE
IG
PLASMA
GRIFOLS USA, LLC
HYPERHEP B
5 ML VIAL
13533-0636-05
VIAL
HYPER IMMUNE
IG
PLASMA
GRIFOLS USA, LLC
NABI-HB
1ML
69800-4202-01
VIAL
HYPER IMMUNE
IG
PLASMA
ADMA BIOLOGICS
NABI-HB
5ML
69800-4203-01
VIAL
HYPER IMMUNE
IG
PLASMA
ADMA BIOLOGICS
RABIES IMMUNE GLOBULIN
HYPERRAB
1 ML
13533-0318-01
VIAL
HYPER IMMUNE
IG
PLASMA
GRIFOLS USA, LLC
ADMA ADvantage Ig TM is a dedicated patient support program created for eligible patients who have been prescribed ADMA Biologics treatment.
HYPERRAB
3 ML
13533-0318-03
VIAL
HYPER IMMUNE
IG
PLASMA
GRIFOLS USA, LLC
HYPERRAB
5 ML
13533-0318-05
VIAL
HYPER IMMUNE
IG
PLASMA
GRIFOLS USA, LLC
Comprehensive Support for Your Practice
Financial Assistance for Your Patients
Prescription Triage
Coverage and Reimbursement Support
HYPERRHO S/D FULL DOSE SYRINGE HYPERRHO S/D FULL DOSE SYRINGE 10PK HYPERRHO S/D MINI- DOSE SYRINGE 10PK
SINGLE
13533-0631-02
SYRINGE
RH IMMUNE
IG
PLASMA
GRIFOLS USA, LLC
10 PACK
13533-0631-11
SYRINGE
RH IMMUNE
IG
PLASMA
GRIFOLS USA, LLC
10 PACK 13533-0661-06
SYRINGE
RH IMMUNE
IG
PLASMA
GRIFOLS USA, LLC
KEDRAB
2 ML
76125-0150-02
VIAL
SPECIALTY
IG
PLASMA
KEDRION BIOPHARMA
KEDRAB
10 ML
76125-0150-10
VIAL
SPECIALTY
IG
PLASMA
KEDRION BIOPHARMA
TETANUS IMMUNE GLOBULIN
HYPERTET
250 IU 13533-0634-02
SYRINGE
HYPER IMMUNE
IG
PLASMA
GRIFOLS USA, LLC
VARICELLA ZOSTER IMMUNE GLOBULIN
Enroll Your Patients Today!
VARIZIG
125 IU
70257-0126-51
VIAL
HYPER IMMUNE
IG
PLASMA SAOL THERAPEUTICS, INC.
RHO(D) IMMUNE GLOBULIN
HYPERRHO S/D FULL DOSE SYRINGE 10PK HYPERRHO S/D MINI- DOSE SYRINGE 10PK
Click here for the ASCENIV Enrollment Form
Click here for the BIVIGAM Enrollment Form
10 PACK
13533-0631-11
SYRINGE
RH IMMUNE
IG
PLASMA
GRIFOLS USA, LLC
10 PACK 13533-0661-06
SYRINGE
RH IMMUNE
IG
PLASMA
GRIFOLS USA, LLC
© 2022 ADMA Biologics. All rights reserved. ASCENIV™ is a trademark of ADMA Biologics.
MICRHOGAM
1 PACK
00562-7806-01
SYRINGE
RH IMMUNE
IG
PLASMA
KEDRION BIOPHARMA
BIVIGAM ® is a registered trademark of ADMA Biologics. ADvantage Ig TM is a trademark of ADMA Biologics. Visit admabiologics.com
19
HG IMMUNOLOGY PRODUCTS - HYPERIMMUNE GLOBULIN Product Name Package Size NDC # Presentation Product Category Subcategory Derivation
IG IMMUNOLOGY PRODUCTS - IMMUNOGLOBULIN Product Name Package Size NDC # Presentation Product Category
Manufacturer
Subcategory Derivation
Manufacturer
BIO PRODUCTS LABORATORIES BIO PRODUCTS LABORATORIES
RHOGAM
1 PACK
00562-7805-01
SYRINGE
RH IMMUNE
IG
PLASMA
KEDRION BIOPHARMA
GAMMAPLEX 5%
5% 10 GRAM 64208-8234-07
VIAL
IVIG
IG
PLASMA
RHOGAM
5 PACK 00562-7805-05 SYRINGE
RH IMMUNE
IG
PLASMA
KEDRION BIOPHARMA
GAMMAPLEX 5%
5% 20 GRAM 64208-8234-08
VIAL
IVIG
IG
PLASMA
RHOGAM
25 PACK 00562-7805-25
SYRINGE
RH IMMUNE
IG
PLASMA
KEDRION BIOPHARMA
GAMUNEX
1 GRAM 13533-0800-12
VIAL
IVIG
IG
PLASMA
GRIFOLS USA, LLC
PACK, 10 SYRINGES
RHOPHYLAC
300 MCG 44206-0300-10
RH IMMUNE
IG
PLASMA
CSL BEHRING LLC
GAMUNEX
2.5 GRAM 13533-0800-15
VIAL
IVIG
IG
PLASMA
GRIFOLS USA, LLC
1000 UG (5000 IU) 300 UG (1500 IU) 500 UG (2500 IU)
WINRHO
70257-0310-51
VIAL
RH IMMUNE
IG
PLASMA SAOL THERAPEUTICS, INC.
GAMUNEX
5 GRAM 13533-0800-20
VIAL
IVIG
IG
PLASMA
GRIFOLS USA, LLC
WINRHO
70257-0330-51
VIAL
RH IMMUNE
IG
PLASMA SAOL THERAPEUTICS, INC.
GAMUNEX
20 GRAM 13533-0800-24
VIAL
IVIG
IG
PLASMA
GRIFOLS USA, LLC
GAMUNEX
40 GRAM 13533-0800-40
VIAL
IVIG
IG
PLASMA
GRIFOLS USA, LLC
WINRHO
70257-0350-51
VIAL
RH IMMUNE
IG
PLASMA SAOL THERAPEUTICS, INC.
GAMUNEX
10 GRAM 13533-0800-71
VIAL
IVIG
IG
PLASMA
GRIFOLS USA, LLC
OCTAGAM 10%
10% 2 GRAM 68982-0850-01
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
IG IMMUNOLOGY PRODUCTS - IMMUNOGLOBULIN Product Name Package Size NDC # Presentation Product Category
OCTAGAM 10%
10% 5 GRAM 68982-0850-02
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
Subcategory Derivation
Manufacturer
OCTAGAM 10%
10% 10 GRAM 68982-0850-03
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
OCTAGAM 10%
10% 20 GRAM 68982-0850-04
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
INTRAVENOUS IMMUNE GLOBULIN
OCTAGAM 10%
10% 30 GRAM 68982-0850-05
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
ASCENIV
5 GRAM 69800-0250-01
VIAL
IVIG
IG
PLASMA
ADMA BIOLOGICS
OCTAGAM 5%
5% 1 GRAM 68982-0840-01
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
BIVIGAM
5 GRAM 69800-6502-01
VIAL
IVIG
IG
PLASMA
ADMA BIOLOGICS
OCTAGAM 5%
5% 2.5 GRAM 68982-0840-02
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
BIVIGAM
10 GRAM 69800-6503-01
VIAL
IVIG
IG
PLASMA
ADMA BIOLOGICS
OCTAGAM 5%
5% 5 GRAM 68982-0840-03
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC.
GAMMAGARD - LIQUID
1 GRAM 00944-2700-02
VIAL
IVIG
IG
PLASMA
OCTAGAM 5%
5% 10 GRAM 68982-0840-04
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
PANZYGA
2.5 GRAM 00069-1109-02
VIAL
IVIG
IG
PLASMA
PFIZER, INC.
GAMMAGARD - LIQUID 2.5 GRAM 00944-2700-03
VIAL
IVIG
IG
PLASMA
PANZYGA
5 GRAM 00069-1224-02
VIAL
IVIG
IG
PLASMA
PFIZER, INC.
GAMMAGARD - LIQUID
5 GRAM 00944-2700-04
VIAL
IVIG
IG
PLASMA
PANZYGA
10 GRAM 00069-1312-02
VIAL
IVIG
IG
PLASMA
PFIZER, INC.
PANZYGA
20 GRAM 00069-1415-02
VIAL
IVIG
IG
PLASMA
PFIZER, INC.
GAMMAGARD - LIQUID
10 GRAM 00944-2700-05
VIAL
IVIG
IG
PLASMA
PANZYGA
30 GRAM 00069-1558-02
VIAL
IVIG
IG
PLASMA
PFIZER, INC.
GAMMAGARD - LIQUID 20 GRAM 00944-2700-06
VIAL
IVIG
IG
PLASMA
PANZYGA
2.5 GRAM 68982-0820-02
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
PANZYGA
5 GRAM 68982-0820-03
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
GAMMAGARD - LIQUID 30 GRAM 00944-2700-07
VIAL
IVIG
IG
PLASMA
PANZYGA
10 GRAM 68982-0820-04
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
GAMMAGARD - S/D
5 GRAM 00944-2656-03
VIAL
IVIG
IG
PLASMA
PANZYGA
20 GRAM 68982-0820-05
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
GAMMAGARD - S/D
10 GRAM 00944-2658-04
VIAL
IVIG
IG
PLASMA
PANZYGA
30 GRAM 68982-0820-06
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
GAMMAKED
1 GRAM 76125-0900-01
VIAL
IVIG
IG
PLASMA
KEDRION BIOPHARMA
PRIVIGEN
5 GRAM 44206-0436-05
VIAL
IVIG
IG
PLASMA
CSL BEHRING LLC
GAMMAKED
10 GRAM 76125-0900-10
VIAL
IVIG
IG
PLASMA
KEDRION BIOPHARMA
PRIVIGEN
10 GRAM 44206-0437-10
VIAL
IVIG
IG
PLASMA
CSL BEHRING LLC
GAMMAKED
20 GRAM 76125-0900-20
VIAL
IVIG
IG
PLASMA
KEDRION BIOPHARMA
PRIVIGEN
20 GRAM 44206-0438-20
VIAL
IVIG
IG
PLASMA
CSL BEHRING LLC
GAMMAKED
5 GRAM 76125-0900-50
VIAL
IVIG
IG
PLASMA
KEDRION BIOPHARMA
PRIVIGEN
40 GRAM 44206-0439-40
VIAL
IVIG
IG
PLASMA
CSL BEHRING LLC
BIO PRODUCTS LABORATORIES BIO PRODUCTS LABORATORIES BIO PRODUCTS LABORATORIES BIO PRODUCTS LABORATORIES
GAMMAPLEX 10%
10% 5 GRAM 64208-8235-05
VIAL
IVIG
IG
PLASMA
SUBCUTANEOUS IMMUNE GLOBULIN
CUTAQUIG
1 GRAM 00069-1061-02
VIAL
SUBQ
IG
PLASMA
PFIZER, INC.
GAMMAPLEX 10%
10% 10 GRAM 64208-8235-06
VIAL
IVIG
IG
PLASMA
CUTAQUIG
2 GRAM 00069-1476-02
VIAL
SUBQ
IG
PLASMA
PFIZER, INC.
GAMMAPLEX 10%
10% 20 GRAM 64208-8235-07
VIAL
IVIG
IG
PLASMA
CUTAQUIG
4 GRAM 00069-1509-02
VIAL
SUBQ
IG
PLASMA
PFIZER, INC.
CUTAQUIG
8 GRAM 00069-1965-02
VIAL
SUBQ
IG
PLASMA
PFIZER, INC.
GAMMAPLEX 5%
5% 5 GRAM 64208-8234-06
VIAL
IVIG
IG
PLASMA
CUTAQUIG
1 GRAM 68982-0810-01
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
21
IG IMMUNOLOGY PRODUCTS - IMMUNOGLOBULIN Product Name Package Size NDC # Presentation Product Category
NP NEUROLOGY PRODUCTS Product Name Package Size NDC #
Product Category
Subcategory Derivation
Manufacturer
Presentation
Subcategory
Derivation
Manufacturer
BRIVIACT ORAL SOLUTION
CUTAQUIG
2 GRAM 68982-0810-03
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
10 MG / ML 50474-0870-15
BOTTLE
SPECIALTY SPECIALTY BRIVARACETAM UCB, INC.
CUTAQUIG
4 GRAM 68982-0810-05
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
BRIVIACT INJECTION 50 MG / 5 ML 50474-0970-75
VIAL
SPECIALTY SPECIALTY BRIVARACETAM UCB, INC.
CUTAQUIG
8 GRAM 68982-0810-06
VIAL
IVIG
IG
PLASMA
OCTAPHARMA USA
HIZENTRA
1 GRAM 44206-0451-01
VIAL
SUBQ
IG
PLASMA
CSL BEHRING LLC
NAYZILAM
5 MG 50474-0500-15 NASAL SPRAY SPECIALTY SPECIALTY BENZODIAZEPINES
UCB, INC.
HIZENTRA
2 GRAM 44206-0452-02
VIAL
SUBQ
IG
PLASMA
CSL BEHRING LLC
KEPPRA ORAL SOLUTION
100 MG / ML 50474-0001-48
BOTTLE
SPECIALTY SPECIALTY LEVETIRACETAM UCB, INC.
HIZENTRA
4 GRAM 44206-0454-04
VIAL
SUBQ
IG
PLASMA
CSL BEHRING LLC
HIZENTRA
10 GRAM 44206-0455-10
VIAL
SUBQ
IG
PLASMA
CSL BEHRING LLC
KEPPRA INJECTION 500 MG / 5ML 50474-0002-63
VIAL
SPECIALTY SPECIALTY LEVETIRACETAM UCB, INC.
HIZENTRA PFS
1 GRAM 44206-0456-21
VIAL
SUBQ
IG
PLASMA
CSL BEHRING LLC
KEPPRA
250 MG 50474-0594-40 BOTTLE
SPECIALTY SPECIALTY LEVETIRACETAM UCB, INC.
HIZENTRA PFS
2 GRAM 44206-0457-22
VIAL
SUBQ
IG
PLASMA
CSL BEHRING LLC
KEPPRA
500 MG 50474-0595-40 BOTTLE
SPECIALTY SPECIALTY LEVETIRACETAM UCB, INC.
HIZENTRA PFS
4 GRAM 44206-0458-24
VIAL
SUBQ
IG
PLASMA
CSL BEHRING LLC
TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC.
KEPPRA
750 MG 50474-0596-40 BOTTLE
SPECIALTY SPECIALTY LEVETIRACETAM UCB, INC.
HYQVIA
2.5 GRAM 00944-2510-02
VIAL
SUBQ
IG
PLASMA
KEPPRA
1000 MG 50474-0597-66
BOTTLE
SPECIALTY SPECIALTY LEVETIRACETAM UCB, INC.
HYQVIA
5 GRAM 00944-2511-02
VIAL
SUBQ
IG
PLASMA
KEPPRA XR
500 MG 50474-0598-66
BOTTLE
SPECIALTY SPECIALTY LEVETIRACETAM UCB, INC.
HYQVIA
10 GRAM 00944-2512-02
VIAL
SUBQ
IG
PLASMA
KEPPRA XR
750 MG 50474-0599-66
BOTTLE
SPECIALTY SPECIALTY LEVETIRACETAM UCB, INC.
LEQEMBI
200 MG / 2 ML 62856-0212-01
VIAL
SPECIALTY SPECIALTY LECANEMAB
EISAI INC.
HYQVIA
20 GRAM 00944-2513-02
VIAL
SUBQ
IG
PLASMA
LEQEMBI
500 MG / 5 ML 62856-0215-01
VIAL
SPECIALTY SPECIALTY LECANEMAB
EISAI INC.
HYQVIA
30 GRAM 00944-2514-02
VIAL
SUBQ
IG
PLASMA
200 MG / 20 ML
VIMPAT INJECTION
00131-1810-67
VIAL
SPECIALTY SPECIALTY LACOSAMIDE
UCB, INC.
XEMBIFY
1 GRAM 13533-0810-05
VIAL
SUBQ
IG
PLASMA
GRIFOLS USA, LLC
VIMPAT
50 MG 00131-2477-35
BOTTLE
SPECIALTY SPECIALTY LACOSAMIDE
UCB, INC.
XEMBIFY
2 GRAM 13533-0810-10
VIAL
SUBQ
IG
PLASMA
GRIFOLS USA, LLC
VIMPAT
50 MG 00131-2477-60 UNIT DOSE PACK SPECIALTY SPECIALTY LACOSAMIDE
UCB, INC.
XEMBIFY
4 GRAM 13533-0810-20
VIAL
SUBQ
IG
PLASMA
GRIFOLS USA, LLC
VIMPAT
100 MG 00131-2478-35
BOTTLE
SPECIALTY SPECIALTY LACOSAMIDE
UCB, INC.
XEMBIFY
10 GRAM 13533-0810-50
VIAL
SUBQ
IG
PLASMA
GRIFOLS USA, LLC
VIMPAT
100 MG 00131-2478-60 UNIT DOSE PACK SPECIALTY SPECIALTY LACOSAMIDE
UCB, INC.
NP NEUROLOGY PRODUCTS Product Name Package Size NDC #
VIMPAT
150 MG 00131-2479-35
BOTTLE
SPECIALTY SPECIALTY LACOSAMIDE
UCB, INC.
Product Category
VIMPAT
150 MG 00131-2479-60 UNIT DOSE PACK SPECIALTY SPECIALTY LACOSAMIDE
UCB, INC.
Presentation
Subcategory
Derivation
Manufacturer
VIMPAT
200 MG 00131-2480-35
BOTTLE
SPECIALTY SPECIALTY LACOSAMIDE
UCB, INC.
AMYOTROPHIC LATERAL SCLEROSIS (ALS)
VIMPAT
200 MG 00131-2480-60 UNIT DOSE PACK SPECIALTY SPECIALTY LACOSAMIDE
UCB, INC.
MITSUBISHI TANABE PHARMA AMERICA, INC.
RADICAVA_ CATEGORY
RADICAVA
30MG/100 ML 70510-2171-02
CARTON
SPECIALTY RECOMBINANT
VIMPAT ORAL SOLUTION
10 MG / ML 00131-5410-72
BOTTLE
SPECIALTY SPECIALTY LACOSAMIDE
UCB, INC.
SEIZURE DISORDERS
PARKINSON’S DISEASE
BRIVIACT
10 MG 50474-0370-66
BOTTLE
SPECIALTY SPECIALTY BRIVARACETAM UCB, INC.
DOPAMINE AGONISTS DOPAMINE AGONISTS DOPAMINE AGONISTS DOPAMINE AGONISTS DOPAMINE AGONISTS DOPAMINE AGONISTS
NEUPRO
30 X 1 MG 50474-0801-03
EACH
SPECIALTY SPECIALTY
UCB, INC.
BRIVIACT
25 MG 50474-0470-09 UNIT DOSE PACK SPECIALTY SPECIALTY BRIVARACETAM UCB, INC.
BRIVIACT
25 MG 50474-0470-66
BOTTLE
SPECIALTY SPECIALTY BRIVARACETAM UCB, INC.
NEUPRO
30 X 2 MG 50474-0802-03
EACH
SPECIALTY SPECIALTY
UCB, INC.
BRIVIACT
50 MG 50474-0570-09 UNIT DOSE PACK SPECIALTY SPECIALTY BRIVARACETAM UCB, INC.
NEUPRO
30 X 3 MG 50474-0803-03
EACH
SPECIALTY SPECIALTY
UCB, INC.
BRIVIACT
50 MG 50474-0570-66
BOTTLE
SPECIALTY SPECIALTY BRIVARACETAM UCB, INC.
NEUPRO
30 X 4 MG 50474-0804-03
EACH
SPECIALTY SPECIALTY
UCB, INC.
BRIVIACT
75 MG 50474-0670-66
BOTTLE
SPECIALTY SPECIALTY BRIVARACETAM UCB, INC.
NEUPRO
30 X 6 MG 50474-0805-03
EACH
SPECIALTY SPECIALTY
UCB, INC.
BRIVIACT
100 MG 50474-0770-09 UNIT DOSE PACK SPECIALTY SPECIALTY BRIVARACETAM UCB, INC.
NEUPRO
30 X 8 MG 50474-0806-03
EACH
SPECIALTY SPECIALTY
UCB, INC.
BRIVIACT
100 MG 50474-0770-66
BOTTLE
SPECIALTY SPECIALTY BRIVARACETAM UCB, INC.
23
Page 1 Page 2-3 Page 4-5 Page 6-7 Page 8-9 Page 10-11 Page 12-13 Page 14-15 Page 16-17 Page 18-19 Page 20-21 Page 22-23 Page 24-25 Page 26-27 Page 28-29 Page 30Powered by FlippingBook